Researchers decipher when and why immune cells fail to respond to immunotherapy, and suggest that T cells need a different kind of prodding in order to re-engage the immune response.
The prevalence of auditory symptoms in Covid-19 patients is unknown, but infection of the inner ears may be responsible for hearing and balance problems.
A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.
The technology could be developed as a rapid diagnostic for Covid-19 or other emerging pathogens.
In the Hoyt C. Hottel Lecture, Arnold tells the story of her pathbreaking research to engineer better enzymes for critical applications.
Professors Linda Griffith and Feng Zhang along with Guillermo Ameer ScD ’99, Darrell Gaskin SM ’87, William Hahn, and Vamsi Mootha recognized for contributions to medicine, health care, and public health.
By combining chemotherapy, tumor injury, and immunotherapy, researchers show that the immune system can be re-engaged to destroy tumors in mice.
While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.
Cardiologist Demilade Adedinsewo is using her MIT Professional Education experience to advance cardiovascular care at the Mayo Clinic.
Secure AI Labs, founded by alumna Anne Kim and MIT Professor Manolis Kellis, anonymizes data for AI researchers.